AZD7442: A cocktail of antibodies to fight Covid-19
Swedish-British drug giant AstraZeneca is moving an antibody combination developed for Covid-19 treatment into late-stage human trials. The firm has also received around $486 million from the US government for the development and supply of this combination. Daily Current Affairs Quiz 2020 Key-Points AZD7442, a similar class of the drug cocktail used to treat US […]
AZD7442: A cocktail of antibodies to fight Covid-19 Read More »










